Back to top

Loxo Oncology (LOXO) Shares March Higher, Can It Continue?
April 17, 2018

Read MoreHide Full Article

As of late, it has definitely been a great time to be an investor in Loxo Oncology, Inc. (LOXO - Free Report) . The stock has moved higher by 12.7% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider LOXO’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as LOXO has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

Breaking News: Cryptocurrencies Now Bigger than Visa

The total market cap of all cryptos recently surpassed $700 billion – more than a 3,800% increase in the previous 12 months. They’re now bigger than Morgan Stanley, Goldman Sachs and even Visa! The new asset class may expand even more rapidly in 2018 as new investors continue pouring in and Wall Street becomes increasingly involved.

Zacks’ has just named 4 companies that enable investors to take advantage of the explosive growth of cryptocurrencies via the stock market.

Click here to access these stocks. >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Loxo Oncology, Inc. (LOXO) - free report >>


More from Zacks Tale of the Tape

You May Like